CW Optics was a First Runner-Up of the Virginia Innovator’s Forum 2010
Seaford, VA (May 4, 2010) - CW Optics, Inc., the developer of optical-based clinical
devices, today announced that it has been selected as a runner-up of the annual
Virginia Innovator’s Forum, for the invention of Laser Speckle Imaging (LSI) technology.
“We are honored to be selected as a runner-up of VIF and are pleased that VIF
recognized the significance of the LSI technology,” said Nee-Yin Chou, Ph.D., CW
Optics President/CEO. “This new generation of noninvasive, proprietary optical imaging
technology provides realtime, critical quantitative blood velocity information to
physicians. It allows immediate diagnosis and more effective therapeutic planning for
enhanced outcomes.”
“Through NIH grant awards of $5 million, we have developed several LSI-based
products, including the Woundlmager™,” said Dr. Chou. “We have tested the
WoundImager™ successfully in an animal study and a human study at two prestigious
university hospitals, and we will begin a clinical trial to further investigate the safety and
efficacy of the Woundlmager™. Our clinical trial partners are two of the highest rated
woundcare hospitals in Virginia. We are also preparing a 510(k) premarket notification
submission to the FDA,” said Dr. Chou.
The company has another product that is currently undergoing clinical trials. The
ivWatch® is a noninvasive optical device used for monitoring intravenous infusions in
patients. It gives realtime warnings when it detects iv fluid leakage. The ivWatch® has
been successfully validated in animal and healthy human studies. The development of
ivWatch® was funded through NIH grants totaling more than $3 million. The ivWatch®
will be ready for commercialization after the company receives an FDA premarket
notification.
This article is also published on virginiainventors.org.
